Evidence map›Paper›PMID 35357214›Full record

ArticlemBio2022

LaNisha L Patterson, Thangam Sudha Velayutham, Caitlan D Byerly, Duc Cuong Bui, Jignesh Patel, Veljko Veljkovic, Slobodan Paessler, Jere W McBride

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Cell signaling inFrontiers in cellular and infection microbiology · 2025
    Review
  4. Host Cells Upregulate Phosphate Transporter PIT1 to InhibitInternational journal of molecular sciences · 2024
    Article
  5. mBio · 2024
    Article
  6. Frontiers in cell and developmental biology · 2024
    Article
  7. Infection and immunity · 2023
    Article
  8. Infection and immunity · 2023
    Article
  9. bioRxiv : the preprint server for biology · 2023
    Article
  10. Article
  11. Type 1 secretion system and effectors in Rickettsiales.Frontiers in cellular and infection microbiology · 2023
    Review
  12. Frontiers in cellular and infection microbiology · 2023
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

LaNisha L PattersonDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0000-0003-1839-5429
Thangam Sudha VelayuthamDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
Caitlan D ByerlyDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
Duc Cuong BuiDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
Jignesh PatelDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
Veljko VeljkovicBiomed Protection, LLC, Galveston, Texas, USA.
Slobodan PaesslerDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0000-0002-2213-9551
Jere W McBrideDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0000-0003-3335-1539
The University of Texas Medical Branch at Galveston · USBiomed Protection (United States) · US

Funding

EMERGING AND TROPICAL INFECTIOUS DISEASEST32AI007526 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI SOONG, LYNN · 1997 to 2025
$3.1M
Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosisR01AI158422 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI JERE W MCBRIDE · 2022 to 2026
$2.0M
Molecular basis of Wnt activation by Ehrlichia Wnt ligand mimicsR21AI149136 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MCBRIDE, JERE W · 2020 to 2021
$426k
Wnt signaling during Ehrlichia infectionR21AI126144 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MCBRIDE, JERE W · 2016 to 2017
$420k
Characterizing Notch Ligand Mimic Function of the Ehrlichia TRP120 Effector in Suppression of Host Cell ApoptosisF31AI152424 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI PATTERSON, LANISHA · 2020 to 2021
$69k
NIAID NIH HHS F31 AI152424NIAID NIH HHS R01 AI158422NIAID NIH HHS R21 AI126144NIAID NIH HHS R21 AI149136NIAID NIH HHS T32 AI007526
6 · The paper itself

Abstract

Ehrlichia chaffeensis evades innate host defenses by reprogramming the mononuclear phagocyte through mechanisms that involve the exploitation of multiple evolutionarily conserved cellular signaling pathways, including Notch. This immune evasion strategy is directed in part by tandem repeat protein (TRP) effectors. Specifically, the TRP120 effector activates and regulates Notch signaling through interactions with the Notch receptor and the negative regulator, F-Box and WD repeat domain-containing 7 (FBW7). However, the specific molecular interactions and motifs required for E. chaffeensis TRP120-Notch receptor interaction and activation have not been defined. To investigate the molecular basis of TRP120 Notch activation, we compared TRP120 with endogenous canonical/noncanonical Notch ligands and identified a short region of sequence homology within the tandem repeat (TR) domain. TRP120 was predicted to share biological function with Notch ligands, and a function-associated sequence in the TR domain was identified. To investigate TRP120-Notch receptor interactions, colocalization between TRP120 and endogenous Notch-1 was observed. Moreover, direct interactions between full-length TRP120, the TRP120 TR domain containing the putative Notch ligand sequence, and the Notch receptor LBR were demonstrated. To molecularly define the TRP120 Notch activation motif, peptide mapping was used to identify an 11-amino acid short linear motif (SLiM) located within the TRP120 TR that activated Notch signaling and downstream gene expression. Peptide mutants of the Notch SLiM or anti-Notch SLiM antibody reduced or eliminated Notch activation and NICD nuclear translocation. This investigation reveals a novel molecularly defined pathogen encoded Notch SLiM mimetic that activates Notch signaling consistent with endogenous ligands.

Indexed as

Ehrlichia chaffeensisEhrlichiosisBacterial ProteinsHost-Pathogen InteractionsHumansLigandsMonocytesReceptors, NotchSignal TransductionBacterial ProteinsLigandsReceptors, NotcheffectorEhrlichialigandmolecular mimicryNotch signalingshort linear motiftandem repeat protein

Identifiers

PMID35357214
PMCPMC9040721
OpenAlexW4225949210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.